Union for International Cancer Control International Session: Healthcare Economics: The significance of the UN summit non‐communicable diseases political declaration in Asia |
| |
Authors: | Hideyuki Akaza Norie Kawahara Tohru Masui Kunihiko Takeyama Masafumi Nogimori Jae Kyung Roh |
| |
Affiliation: | 1. Department of Strategic Investigation on Comprehensive Cancer Network, Research Center for Advanced Science and Technology (RCAST), The University of Tokyo, , Tokyo, Japan;2. National Institute of Biomedical Innovation, , Osaka;3. Oncology Business Unit, Sanofi, , Kabushiki Kaisya, Tokyo;4. Astellas Pharma, , Tokyo, Japan;5. Yonsei University College of Medicine, , Seoul, Korea |
| |
Abstract: | The Japan National Committee for the Union for International Cancer Control (UICC) and UICC‐Asia Regional Office (ARO) organized an international session as part of the official program of the 71st Annual Meeting of the Japanese Cancer Association to discuss the topic “Healthcare Economics: The Significance of the UN Summit non‐communicable diseases (NCDs) Political Declaration in Asia.” The presenters and participants discussed the growing cost of cancer in the Asian region and the challenges that are faced by the countries of Asia, all of which face budgetary and other systemic constraints in tackling and controlling cancer in the region. The session benefited from the participation of various stakeholders, including cancer researchers and representatives of the pharmaceutical industry. They discussed the significance of the UN Political Declaration on the prevention and control of NCDs (2011) as a means of boosting awareness of cancer in the Asian region and also addressed the ways in which stakeholders can cooperate to improve cancer control and treatment. Other issues that were covered included challenges relating to pharmaceutical trials in Asia and how to link knowledge and research outcomes. The session concluded with the recognition that with the onset of a super‐aged society in most countries in Asia and an increasing focus on quality of life rather than quantity of life, it is more important than ever for all stakeholders to continue to share information and promote policy dialogue on cancer control and treatment. |
| |
Keywords: | |
|
|